Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Repeated electroconvulsive stimuli have long-lasting effects on hippocampal BDNF and decrease immobility time in the

Bingjin Li1, Katsuya Suemaru, Ranji Cui

  • 1Department of Clinical Pharmacology and Pharmacy, Ehime University Graduate School of Medicine, Shitsukawa Toon, Ehime, Japan.

Life Sciences
|February 20, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Chlorogenic acid (CGA) exerts antidepressant-like effects by regulating SIRT1/FoxO3a/PINK1/Parkin pathway in LPS-induced depressive mice.

Cellular signalling·2026
Same author

Effects of Single Bolus Exposure to Propofol on Depression-like Behavior in a Chronic Unpredictable Mild Stress Model in Mice.

Anesthesiology·2026
Same author

The anticonvulsant activity of trace amine-associated receptor 1 (TAAR1) agonists involves GABA<sub>B</sub> receptors in mice.

European journal of pharmacology·2025
Same author

Ginsenoside Rd alleviates LPS-induced neuroinflammation and depressive-like behaviors via regulating TLR4-PI3K-NF-κB-JMJD3 signaling.

International immunopharmacology·2025
Same author

Calcium imaging: Unraveling the neurobiological mechanisms of depression across cellular and circuit dimensions.

Cell calcium·2025
Same author

Exploring the Effect and Mechanism of Liraglutide in Treating Depression Based on Network Pharmacology and Experimental Analysis.

Journal of cellular and molecular medicine·2025
Same journal

Corrigendum to "Adipose stem cells-derived microvesicles and chicken egg-derived exosomes attenuate cardiac ischemia/reperfusion injury through AKT/ERK/Nrf2/HO-1 axis to inhibit apoptosis and inflammation and restore autophagy" [Life Sci. 395 (2026) 124364].

Life sciences·2026
Same journal

MAGED1 stabilizes NEUROD1 to promote Per3 expression in the pineal gland.

Life sciences·2026
Same journal

TNF-centered network pharmacology and molecular modeling of selected Andrographis paniculata compounds in hypertension.

Life sciences·2026
Same journal

Retraction notice to "Beneficial effect of Calculus Bovis Sativus on 17α-ethynylestradiol-induced cholestasis in the rat" [Life Sci. 113 (2014) 22-30].

Life sciences·2026
Same journal

Soluble PD-1 drives renal fibrosis in CKD by disrupting immune homeostasis: Therapeutic mitigation via a targeted sPD-1 sequestration strategy.

Life sciences·2026
Same journal

METTL1 promotes hepatic steatosis by mediating m<sup>7</sup>G modification of ALOX15B mRNA.

Life sciences·2026
See all related articles

Electroconvulsive therapy (ECT) effectively treats depression by increasing brain-derived neurotrophic factor (BDNF) and locomotor activity. This study shows ECT

Area of Science:

  • Neuroscience
  • Pharmacology
  • Psychiatry

Background:

  • Electroconvulsive therapy (ECT) is a recognized treatment for severe depression.
  • The precise mechanisms underlying ECT's sustained antidepressant effects remain unclear.
  • Understanding these mechanisms is crucial for optimizing depression treatment.

Purpose of the Study:

  • To investigate the effects of repeated electroconvulsive stimuli (ECS) on immobility time and brain-derived neurotrophic factor (BDNF) levels in rats.
  • To determine the duration of these effects following ECS withdrawal.

Main Methods:

  • Rats received 14 days of repeated electroconvulsive stimuli (ECS).
  • Immobility time was assessed using the forced swim test.
  • Locomotor activity was measured in an open-field test.

Related Experiment Videos

  • Hippocampal BDNF protein levels were quantified.

    • Main Results:

    • ECS significantly reduced immobility time 6 hours after withdrawal, with effects lasting up to 3 days.
    • Locomotor activity increased post-ECS and remained elevated for at least 7 days.
    • Hippocampal BDNF protein levels showed a marked increase 6 hours after withdrawal, sustained for at least 7 days.

    Conclusions:

    • Repeated ECS administration leads to long-lasting increases in hippocampal BDNF.
    • These neurobiological changes correlate with reduced immobility and enhanced locomotor activity.
    • Findings suggest BDNF modulation plays a key role in ECT's antidepressant efficacy.